|

Nedaplatin Clinical Trials

4 actively recruiting trials

Also known as: NDP

Pipeline

Phase 2: 2Phase 3: 2

Top Sponsors

  • Zhejiang Cancer Hospital1
  • Fuzhou General Hospital1
  • Beijing Tongren Hospital1
  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University1

Indications

  • Cancer4
  • Liver Metastasis of Breast Cancer1
  • Hepatic Artery Infusion1
  • Pembrolizumab1
  • Immunotherapy Esophagus Cancer1

Other4 trials

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Phase 3
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
Phase 2
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Phase 3
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.